Genome-wide significant risk factors on chromosome 19 and the APOE locus

The apolipoprotein E (APOE) gene on chromosome 19q13.32, was the first, and remains the strongest, genetic risk factor for Alzheimer’s disease (AD). Additional signals associated with AD have been located in chromosome 19, including ABCA7 (19p13.3) and CD33 (19q13.41). The ABCA7 gene has been replicated in most populations. However, the contribution to AD of other signals close to APOE gene remains controversial. Possible explanations for inconsistency between reports include long range linkage disequilibrium (LRLD). We analysed the contribution of ABCA7 and CD33 loci to AD risk and explore LRLD patterns across APOE region. To evaluate AD risk conferred by ABCA7 rs4147929:G>A and CD33 rs3865444:C>A, we used a large Spanish population (1796 AD cases, 2642 controls). The ABCA7 rs4147929:G>A SNP effect was nominally replicated in the Spanish cohort and reached genome-wide significance after meta-analysis (odds ratio (OR)=1.15, 95% confidence interval (95% CI)=1.12–1.19; P = 1.60 x 10-19). CD33 rs3865444:C>A was not associated with AD in the dataset. The meta-analysis was also negative (OR=0.98, 95% CI=0.93–1.04; P=0.48). After exploring LRLD patterns between APOE and CD33 in several datasets, we found significant LD (D’ >0.20; P <0.030) between APOE-Ɛ2 and CD33 rs3865444C>A in two of five datasets, suggesting the presence of a non-universal long range interaction between these loci affecting to some populations. In conclusion, we provide here evidence of genetic association of the ABCA7 locus in the Spanish population and also propose a plausible explanation for the controversy on the contribution of CD33 to AD susceptibility.

[1]  B. Nordestgaard,et al.  ABCA7 and risk of dementia and vascular disease in the Danish population , 2017, Annals of clinical and translational neurology.

[2]  Francisco Lopera,et al.  Association of GWAS Top Genes With Late-Onset Alzheimer’s Disease in Colombian Population , 2017, American journal of Alzheimer's disease and other dementias.

[3]  A. Ruiz,et al.  Genome research in pre-dementia stages of Alzheimer's disease , 2016, Expert Reviews in Molecular Medicine.

[4]  Xianlin Han,et al.  ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology , 2016, The Journal of Neuroscience.

[5]  Y. Fang,et al.  CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer’s Disease , 2016, Neuropsychopharmacology.

[6]  Mary Miu Yee Waye,et al.  Polygenic Analysis of Late-Onset Alzheimer’s Disease from Mainland China , 2015, PloS one.

[7]  J. Pu,et al.  Association of CD33 and MS4A cluster variants with Alzheimer’s disease in East Asian populations , 2015, Neuroscience Letters.

[8]  M. Calus,et al.  Estimation of inbreeding using pedigree, 50k SNP chip genotypes and full sequence data in three cattle breeds , 2015, BMC Genetics.

[9]  M. Nöthen,et al.  PLD3 in non-familial Alzheimer's disease , 2015, Nature.

[10]  Perry G. Ridge,et al.  Population-based Analysis of Alzheimer’s Disease Risk Alleles Implicates Genetic Interactions , 2014, Biological Psychiatry.

[11]  H. Feldman,et al.  Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population , 2014, Neurobiology of Aging.

[12]  M. Nöthen,et al.  Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene , 2014, Translational Psychiatry.

[13]  Erick R. Scott,et al.  Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease , 2013, Nature.

[14]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[15]  Wei Wang,et al.  Association of GWAS-linked loci with late-onset Alzheimer's disease in a northern Han Chinese population , 2013, Alzheimer's & Dementia.

[16]  Mark T. W. Ebbert,et al.  Genetics of Alzheimer's Disease , 2013, BioMed research international.

[17]  S. Chung,et al.  Association of GWAS Top Hits With Late-onset Alzheimer Disease in Korean Population , 2013, Alzheimer disease and associated disorders.

[18]  Keith A. Johnson,et al.  CD33 Alzheimer’s disease locus: Altered monocyte function and amyloid biology , 2013, Nature Neuroscience.

[19]  Oscar L Lopez,et al.  Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. , 2013, JAMA.

[20]  J. Haines,et al.  SORL1 Is Genetically Associated with Late-Onset Alzheimer’s Disease in Japanese, Koreans and Caucasians , 2013, PloS one.

[21]  D. Elliott,et al.  Deletion of Abca7 Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease , 2013, The Journal of Neuroscience.

[22]  W. Xu,et al.  The prevalence of CD33 and MS4A6A variant in Chinese Han population with Alzheimer’s disease , 2012, Human Genetics.

[23]  Robert C Green,et al.  A comprehensive genetic association study of Alzheimer disease in African Americans. , 2011, Archives of neurology.

[24]  David M Holtzman,et al.  Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease. , 2011, Archives of neurology.

[25]  V. Pankratz,et al.  Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study , 2011, Molecular Neurodegeneration.

[26]  James T Becker,et al.  The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease , 2011, Genome Medicine.

[27]  D. G. Clark,et al.  Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.

[28]  Nick C Fox,et al.  Common variants in ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease , 2011, Nature Genetics.

[29]  E. Wijsman,et al.  Genome-Wide Association of Familial Late-Onset Alzheimer's Disease Replicates BIN1 and CLU and Nominates CUGBP2 in Interaction with APOE , 2011, PLoS genetics.

[30]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[31]  A D Roses,et al.  A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.

[32]  M. Bullido,et al.  Apolipoprotein E genotyping method by Real Time PCR, a fast and cost-effective alternative to the TaqMan® and FRET assays , 2009, Journal of Neuroscience Methods.

[33]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[34]  X. Estivill,et al.  Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability , 2007, Nature Reviews Genetics.

[35]  P. Linsel-Nitschke,et al.  ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages , 2006, The Journal of cell biology.

[36]  Elizabeth L. Ogburn,et al.  Demonstrating stratification in a European American population , 2005, Nature Genetics.

[37]  Jakob C. Mueller,et al.  Linkage disequilibrium for different scales and applications , 2004, Briefings Bioinform..

[38]  Lon R. Cardon,et al.  A first-generation linkage disequilibrium map of human chromosome 22 , 2002, Nature.

[39]  L. Kruglyak,et al.  Patterns of linkage disequilibrium in the human genome , 2002, Nature Reviews Genetics.

[40]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[41]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[42]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.